The Histone Deacetylase Inhibitor LAQ824 Induces Human Leukemia Cell Death through a Process Involving XIAP Down-Regulation, Oxidative Injury, and the Acid Sphingomyelinase-Dependent Generation of Ceramide
Type
Retraction
Notice date
3/1/2019 0:00
Journal
Molecular Pharmacology
Publisher
ASPET: American Society for Pharmacology and Experimental Therapeutics